Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-21-004557
Filing Date
2021-04-21
Accepted
2021-04-21 16:30:27
Documents
10
Period of Report
2021-06-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20210602xdef14a.htm DEF 14A 1126481
2 GRAPHIC tmb-20210602xdef14a004.jpg GRAPHIC 5810
3 GRAPHIC tmb-20210602xdef14a011.jpg GRAPHIC 5015
4 GRAPHIC tmb-20210602xdef14a014.jpg GRAPHIC 4982
5 GRAPHIC tmb-20210602xdef14a033.jpg GRAPHIC 71213
6 GRAPHIC tmb-20210602xdef14a012.jpg GRAPHIC 3286
7 GRAPHIC tmb-20210602xdef14a032.jpg GRAPHIC 105257
8 GRAPHIC tmb-20210602xdef14a013.jpg GRAPHIC 3865
9 GRAPHIC tmb-20210602xdef14a015.jpg GRAPHIC 3490
10 GRAPHIC tmb-20210602xdef14a005.jpg GRAPHIC 3946
  Complete submission text file 0001558370-21-004557.txt   1413715
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37359 | Film No.: 21841869
SIC: 2834 Pharmaceutical Preparations